lutetium has been researched along with Experimental Neoplasms in 22 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (4.55) | 18.7374 |
| 1990's | 3 (13.64) | 18.2507 |
| 2000's | 3 (13.64) | 29.6817 |
| 2010's | 14 (63.64) | 24.3611 |
| 2020's | 1 (4.55) | 2.80 |
| Authors | Studies |
|---|---|
| Chang, MC; Chen, CT; Chiang, PF; Peng, CL; Shih, YH | 1 |
| Camacho-López, M; Isaac-Olivé, K; Jiménez-Mancilla, N; Mendoza-Nava, H; Ramírez-Nava, G; Torres-García, E | 1 |
| Adam, MJ; Cawthray, JF; Lewis, JS; Orvig, C; Price, EW; Ramogida, CF; Ramos, N; Zeglis, BM | 1 |
| Haller, S; Leamon, CP; Müller, C; Reber, J | 1 |
| Bernhardt, P; Dorrer, H; Haller, S; Müller, C; Reber, J; Schibli, R; Türler, A; Zhernosekov, K | 1 |
| Boerman, OC; Bos, DL; Mulders, PF; Muselaers, CH; Oosterwijk, E; Oyen, WJ | 1 |
| Ahmadi, M; Bacot, S; Boturyn, D; Bourre, JC; Bozon-Petitprin, A; Broisat, A; Claron, M; Fagret, D; Gauchez, AS; Ghezzi, C; Marti-Batlle, D; Perret, P; Riou, LM; Vuillez, JP | 1 |
| Balkin, ER; Jia, F; Lewis, MR; Liu, D; Ruthengael, VC; Smith, CJ | 1 |
| Attayek, P; Huang, L; Midkiff, B; Satterlee, AB | 1 |
| Beran, M; Eigner, S; Henke, KE; Lebeda, O; Melichar, F; Vera, DR | 1 |
| Banerjee, S; Das, T; Mishra, KP; Sarma, HD; Venkatesh, M; Vidyasagar, PB | 1 |
| Frangioni, JV; Orcutt, KD; Rhoden, JJ; Ruiz-Yi, B; Wittrup, KD | 1 |
| Abbas, N; Brevik, EM; Bruland, ØS; Dahle, J | 1 |
| Wiwanitkit, V | 1 |
| Dahle, J; Larsen, RH; Lassmann, M; Mollatt, C; Repetto-Llamazares, AH | 1 |
| Buchsbaum, DJ; Roberson, PL; Rogers, BE; Yokoyama, S | 1 |
| Aarts, F; Bleichrodt, RP; Boerman, OC; Hendriks, T; Koppe, MJ; Oyen, WJ | 1 |
| Gössner, W; Luz, A; Müller, WA; Schäffer, EH | 1 |
| Ehrenberg, B; Kostenich, G; Malik, Z; Orenstein, A; Roitman, L | 1 |
| Dow, WC; Fan, Q; Hemmi, G; Kessel, D; Magda, D; Miller, RA; Mody, TD; Sessler, JL; Woodburn, KW; Wright, M; Young, SW | 1 |
| Berns, MW; Ghahramanlou, M; Hammer-Wilson, MJ; Sun, CH | 1 |
| Anderson, CJ; Bugaj, JE; Erion, JL; Laforest, R; Lewis, JS; Srinivasan, A; Wang, F; Wang, M | 1 |
22 other study(ies) available for lutetium and Experimental Neoplasms
| Article | Year |
|---|---|
Multifunctional Cyanine-Based Theranostic Probe for Cancer Imaging and Therapy.
Topics: A549 Cells; Animals; Female; Fluorescent Dyes; HCT116 Cells; Humans; Lutetium; Mice; Mice, Nude; Neoplasms, Experimental; Optical Imaging; Quinolinium Compounds; Radioisotopes; Single Photon Emission Computed Tomography Computed Tomography; Theranostic Nanomedicine | 2021 |
Theoretical and experimental characterization of emission and transmission spectra of Cerenkov radiation generated by 177Lu in tissue.
Topics: Animals; Beta Particles; Cell Line, Tumor; Electromagnetic Radiation; Feasibility Studies; Humans; Lutetium; Mice; Mice, Nude; Neoplasms, Experimental; Optical Imaging; Radioisotopes; Radiopharmaceuticals | 2019 |
H(4)octapa-trastuzumab: versatile acyclic chelate system for 111In and 177Lu imaging and therapy.
Topics: Animals; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Chelating Agents; Ethylamines; Female; Heterocyclic Compounds, 1-Ring; Humans; Indium Radioisotopes; Lutetium; Mice; Mice, Nude; Models, Molecular; Molecular Structure; Neoplasm Transplantation; Neoplasms, Experimental; Pyridines; Radiopharmaceuticals; Tissue Distribution; Trastuzumab; Tumor Cells, Cultured; Xenograft Model Antitumor Assays | 2013 |
177Lu-EC0800 combined with the antifolate pemetrexed: preclinical pilot study of folate receptor targeted radionuclide tumor therapy.
Topics: Animals; Cell Line, Tumor; Combined Modality Therapy; Coordination Complexes; Drug Evaluation, Preclinical; Female; Folate Receptors, GPI-Anchored; Folic Acid; Folic Acid Antagonists; Glutamates; Guanine; Humans; KB Cells; Lutetium; Male; Mice; Mice, Nude; Neoplasms, Experimental; Pemetrexed; Pilot Projects; Radioisotopes; Radiopharmaceuticals; Xenograft Model Antitumor Assays | 2013 |
Direct in vitro and in vivo comparison of (161)Tb and (177)Lu using a tumour-targeting folate conjugate.
Topics: Animals; Coordination Complexes; Female; Folic Acid; HeLa Cells; Humans; Lutetium; Mice; Mice, Nude; Neoplasms, Experimental; Radioisotopes; Radiopharmaceuticals; Terbium; Tomography, Emission-Computed, Single-Photon; Xenograft Model Antitumor Assays | 2014 |
Optimizing lutetium 177-anti-carbonic anhydrase IX radioimmunotherapy in an intraperitoneal clear cell renal cell carcinoma xenograft model.
Topics: Animals; Antibodies, Monoclonal; Carcinoma, Renal Cell; Cell Line, Tumor; Coordination Complexes; Dose-Response Relationship, Radiation; Heterocyclic Compounds, 1-Ring; Heterografts; Humans; Immunoconjugates; Injections, Intraperitoneal; Kidney Neoplasms; Lutetium; Maximum Tolerated Dose; Mice; Neoplasm Transplantation; Neoplasms, Experimental; Radioimmunotherapy; Radioisotopes; Radiopharmaceuticals; Tissue Distribution | 2014 |
Targeted radionuclide therapy with RAFT-RGD radiolabelled with (90)Y or (177)Lu in a mouse model of αvβ3-expressing tumours.
Topics: Animals; Cell Line, Tumor; Humans; Integrin alphaVbeta3; Lutetium; Mice; Mice, Nude; Neoplasms, Experimental; Peptides, Cyclic; Radiopharmaceuticals; Tissue Distribution; Xenograft Model Antitumor Assays; Yttrium Radioisotopes | 2015 |
Targeted antisense radiotherapy and dose fractionation using a (177)Lu-labeled anti-bcl-2 peptide nucleic acid-peptide conjugate.
Topics: Animals; Cell Line, Tumor; Combined Modality Therapy; Dose Fractionation, Radiation; Female; Genetic Therapy; Isotope Labeling; Lutetium; Mice; Mice, SCID; Molecular Targeted Therapy; Nanoconjugates; Neoplasms, Experimental; Oligonucleotides, Antisense; Peptide Nucleic Acids; Proto-Oncogene Mas; Proto-Oncogene Proteins c-bcl-2; Radioisotopes; Radiopharmaceuticals; Treatment Outcome | 2015 |
A dosimetric model for the heterogeneous delivery of radioactive nanoparticles In vivo: a feasibility study.
Topics: Animals; Brachytherapy; Cell Line, Tumor; Feasibility Studies; Female; Humans; Imaging, Three-Dimensional; Lutetium; Mice; Mice, Nude; Models, Theoretical; Nanoparticles; Neoplasms, Experimental; Radioisotopes; Radiometry; Radiotherapy Planning, Computer-Assisted | 2017 |
Preparation and preclinical evaluation of 177Lu-nimotuzumab targeting epidermal growth factor receptor overexpressing tumors.
Topics: Animals; Antibodies, Monoclonal, Humanized; Carcinoma, Squamous Cell; ErbB Receptors; Humans; Immunoconjugates; Immunologic Factors; Lutetium; Mice; Mice, Inbred BALB C; Neoplasms, Experimental; Radiation Dosage; Radioimmunotherapy; Radioisotopes; Tissue Distribution | 2012 |
Studies on efficacy of a novel 177Lu-labeled porphyrin derivative in regression of tumors in mouse model.
Topics: Animals; Female; Fibrosarcoma; Lutetium; Lymphoma; Mice; Neoplasms, Experimental; Porphyrins; Radioisotopes; Radiopharmaceuticals; Thymus Neoplasms; Tissue Distribution | 2011 |
Effect of small-molecule-binding affinity on tumor uptake in vivo: a systematic study using a pretargeted bispecific antibody.
Topics: Animals; Antibodies, Bispecific; Carcinoembryonic Antigen; Cells, Cultured; Chelating Agents; Coordination Complexes; Haptens; Heterocyclic Compounds, 1-Ring; Humans; Indium Radioisotopes; Lutetium; Mice; Mice, Nude; Models, Biological; Neoplasm Transplantation; Neoplasms, Experimental; Radioimmunotherapy; Radioisotopes; Radiopharmaceuticals; Tissue Distribution; Transplantation, Heterologous | 2012 |
Preclinical evaluation of 227Th-labeled and 177Lu-labeled trastuzumab in mice with HER-2-positive ovarian cancer xenografts.
Topics: Animals; Antibodies, Monoclonal, Humanized; Antibodies, Monoclonal, Murine-Derived; Female; Lutetium; Mice; Neoplasms, Experimental; Organometallic Compounds; Ovarian Neoplasms; Platelet Count; Radioisotopes; Receptor, ErbB-2; Rituximab; Tissue Distribution; Trastuzumab; Treatment Outcome | 2012 |
177Lu-nimotuzumab.
Topics: Animals; Antibodies, Monoclonal, Humanized; Carcinoma, Squamous Cell; Humans; Lutetium; Neoplasms, Experimental; Radioisotopes | 2012 |
Biodistribution and dosimetry of (177)Lu-tetulomab, a new radioimmunoconjugate for treatment of non-Hodgkin lymphoma.
Topics: Animals; Case-Control Studies; Female; Humans; Lutetium; Lymphoma, Non-Hodgkin; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Neoplasms, Experimental; Radiation Dosage; Radioisotopes; Tissue Distribution | 2013 |
Three-dimensional dose model for the comparison of 177Lu-HuCC49DeltaCH2 and 177Lu-HuCC49 radioimunotherapy in mice bearing intraperitoneal xenografts.
Topics: Aniline Compounds; Animals; Antibodies, Monoclonal; Colonic Neoplasms; Dose-Response Relationship, Radiation; Heterocyclic Compounds; Humans; Lutetium; Mice; Mice, Nude; Models, Biological; Neoplasms, Experimental; Peritoneal Neoplasms; Radioimmunotherapy; Radiotherapy Dosage; Tissue Distribution; Transplantation, Heterologous | 2003 |
A comparison between radioimmunotherapy and hyperthermic intraperitoneal chemotherapy for the treatment of peritoneal carcinomatosis of colonic origin in rats.
Topics: Animals; Antibiotics, Antineoplastic; Antibodies, Monoclonal; Body Weight; Colonic Neoplasms; Combined Modality Therapy; Disease Models, Animal; Hyperthermia, Induced; Infusions, Parenteral; Lutetium; Mitomycin; Neoplasms, Experimental; Peritoneal Neoplasms; Radioimmunotherapy; Rats; Rats, Inbred Strains; Survival Rate; Treatment Outcome | 2007 |
The role of time-factor and RBE for the induction of osteosarcomas by incorporated short-lived bone-seekers.
Topics: Animals; Bone Neoplasms; Lutetium; Male; Mice; Mice, Inbred Strains; Neoplasms, Experimental; Neoplasms, Radiation-Induced; Osteosarcoma; Radioisotopes; Radium; Relative Biological Effectiveness; Strontium Radioisotopes; Thorium; Time Factors | 1983 |
In vivo photodynamic therapy with the new near-IR absorbing water soluble photosensitizer lutetium texaphyrin and a high intensity pulsed light delivery system.
Topics: Animals; Dihematoporphyrin Ether; Female; Foot; Lasers; Lutetium; Metalloporphyrins; Mice; Mice, Inbred BALB C; Molecular Structure; Neoplasms, Experimental; Photochemotherapy; Photosensitizing Agents; Porphyrins; Solubility; Spectrometry, Fluorescence; Water | 1997 |
Phototherapy of cancer and atheromatous plaque with texaphyrins.
Topics: Animals; Antineoplastic Agents; Argon; Arteriosclerosis; Cholesterol; Gadolinium; Laser Therapy; Lutetium; Male; Metalloporphyrins; Mice; Mice, Inbred DBA; Neoplasms, Experimental; Photochemotherapy; Photosensitizing Agents; Rabbits; Survival Analysis; Tumor Cells, Cultured | 1996 |
In vitro and in vivo comparison of argon-pumped and diode lasers for photodynamic therapy using second-generation photosensitizers.
Topics: Animals; Cell Line; Cricetinae; Drug Screening Assays, Antitumor; Female; In Vitro Techniques; Indoles; Laser Therapy; Lutetium; Metalloporphyrins; Mice; Mice, Inbred DBA; Neoplasm Transplantation; Neoplasms, Experimental; Organometallic Compounds; Ovary; Photochemotherapy; Photosensitizing Agents; Porphyrins | 1998 |
Toxicity and dosimetry of (177)Lu-DOTA-Y3-octreotate in a rat model.
Topics: Animals; Lutetium; Male; Neoplasms, Experimental; Octreotide; Radiopharmaceuticals; Radiotherapy Dosage; Rats; Rats, Inbred Lew | 2001 |